Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

138.70
+0.08000.06%
Post-market: 139.200.5000+0.36%19:46 EDT
Volume:1.89M
Turnover:263.70M
Market Cap:264.64B
PE:20.97
High:141.46
Open:140.58
Low:138.28
Close:138.62
52wk High:170.46
52wk Low:121.57
Shares:1.91B
Float Shares:1.85B
Volume Ratio:0.75
T/O Rate:0.10%
Dividend:4.67
Dividend Rate:3.36%
EPS(TTM):6.61
EPS(LYR):7.15
ROE:30.35%
ROA:10.25%
PB:6.37
PE(LYR):19.40

Loading ...

Novartis Bolsters Oncology Pipeline with $1.5 Billion Acquisition of Myricx Bio

Stock News
·
Jul 06

Novartis's Myricx Bio Upfront Payment Looks High

Dow Jones
·
Jul 06

Movement Alert|Novartis Rises 3.01% in Regular Trading, Spinal Muscular Atrophy Gene Therapy Wins EU Approval

Market Focus
·
Jul 02

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Thursday Amid Latest Economic Reports

MT Newswires Live
·
Jul 02

Novartis Wins European Approval For Spinal Muscular Atrophy Gene Therapy

MT Newswires Live
·
Jul 02

Novartis, Antares Therapeutics Sign Oncology Drug Discovery Deal Worth Up to $1.9 Billion

MT Newswires Live
·
Jun 24

Movement Alert|Novartis Rises 3.01% in Regular Trading, Antibody-Conjugated Oligonucleotide Drug Delivers Positive Early Clinical Data

Market Focus
·
Jun 24

Switzerland Voted Against a Population Cap but This Isn't the Last We'll Hear About It -- Barrons.com

Dow Jones
·
Jun 19

Novartis' Rhapsido Meets Primary Endpoints in Chronic Inducible Urticaria Trial

MT Newswires Live
·
Jun 12

Analysts Have Conflicting Sentiments on These Healthcare Companies: Eli Lilly & Co (LLY), Insulet (PODD) and Novartis (NVS)

TIPRANKS
·
Jun 12

Sector Update: Healthcare Stocks Rise Thursday Afternoon

MT Newswires Live
·
Jun 12

Movement Alert|Novartis Rises 3.11% in Pre-Market Trading, Multiple Pipeline Catalysts Drive Positive Sentiment

Market Focus
·
Jun 11

Bank of America Securities Remains a Buy on Novartis (NVS)

TIPRANKS
·
Jun 11

Novartis announces biomarker cohort in study of del-brax met primary endpoint

TIPRANKS
·
Jun 11

Novartis Says Early-to-Mid Stage Study for Muscular Dystrophy Drug Meets Main Goal

MT Newswires Live
·
Jun 11

Novartis $12 Billion Bet on Avidity Is Starting to Pay Off -- Market Talk

Dow Jones
·
Jun 11

Novartis Could Move Forward Neuromuscular Drug Approval After Early Data -- Market Talk

Dow Jones
·
Jun 11

Europe's Big Pharma Could Win Investors' Favor With Busy End of Year -- Market Talk

Dow Jones
·
Jun 10

Why a U.K. pharma giant is paying a 40% premium to pivot back to oncology

Dow Jones
·
Jun 09

GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down

Dow Jones
·
Jun 09